29th Annual J. Garber Galbraith, MD Scientific Session and Lecture
The Twenty-Ninth Annual J. Garber Galbraith, MD Scientific Session and Lecture took place November 2, 2012. Along with the faculty, the J. Garber Galbraith Lecturer, Daniel L. Barrow, MD evaluated qualifying resident presentations and abstracts. Presenters with the highest scores for content, organization, and delivery received awards for their research.
2012 Award Winners, Left to right: Third place – Richard B. Morawetz, M.D., Resident Prize for Research: Martin Mortazavi, M.D.; Second place – Griffith Rutherford Harsh III, M.D., Resident Prize for Research: Daxa Patel, M.D.; First place – James Garber Galbraith, M.D., Resident Prize for Research: Thomas Whisenhunt, M.D.
UAB Neurosurgery Granted Departmental Status
The Division of Neurosurgery will become the Department of Neurosurgery on October 1, 2013, elevating the profile of an already world-renowned program. To read the article on the School of Medicine’s website, click here. For further reading, visit these sites:
Dr. James M. Markert Elected Fellow of the American Surgical Association
James M. Markert, MD was elected a Fellow of the American Surgical Association (ASA) at their annual meeting in April 2013. ASA is America’s oldest and most prestigious surgical association, whose members are the world’s leading surgeons. The mission of the ASA ”is to be the premier organization for surgical science and scholarship and to provide a national forum for presenting the developing state of the art and science of general and sub-specialty surgery and the elevation of the standards of the medical/surgical profession.”
UAB Neurosurgeons Ranked Among the Top One Percent in the Nation by Peers
UAB physicians James M. Markert, MD; Barton L. Guthrie, MD; Mark N. Hadley, MD; and Jerry W. Oakes, MD have been recognized by a group of their peers for their outstanding work in neurosurgery. They have also been identified as the top 1% in their field by U.S. News Top Doctors.
Dr. Mark N. Hadley Named Director of the American Board of Neurological Surgery
![hadley](/medicine/neurosurgery/images/faculty/hadley.jpg)
ABNS is the primary professional organization in the field of neurosurgery and is the agency that approves board-certification for neurosurgeons. ABNS also works to maintain and elevate professional standards in the field and encourage the study and improve the practice of neurosurgery.
"Selection as a director of the ABNS is a great honor that brings with it great responsibility," said James Markert, M.D., Ph.D., division director for neurosurgery at UAB. "Mark Hadley is an outstanding choice to advance the goals of the ABNS, as he has demonstrated time and again throughout his career that he is a superlative surgeon, educator and researcher."
Cytochrome c Oxidase in Glioma: A Potential Marker and Therapeutic Target
In UAB's Division of Neurosurgery, Corinne E. Griguer, PhD and her research team is searching for potential therapeutic targets in malignant glioma. A recent recipient of a Research Project Grant, her research interests include exploring the bioenergetic pathways involved in the development and progression of malignant glioma. Patient chemoresistance to temozolomide (TMZ), the frontline drug of choice to treat glioblastoma multiforme, limits treatment options. Griguer and her colleagues at the Southern Research Institute and University of Geneva have determined that increased cytochrome c oxidase (CcO) activity is associated with TMZ resistance in glioblastoma multiforme. In the future, analysis of CcO activity in gliomas may be used to predict overall survival and progression free survivals in patients with malignant glioma. CcO activity may serve as a target for small molecule inhibitiors that could be used to block acquisition of chemoresistance in glioma. Reversing TMZ insensitivity may lead to improved outcomes in patients with GBM.